A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease. Crohn’s Disease cA2 Study Group. - Targan,S.R.; Hanauer,S.B.; van Deventer,S.J. (N Engl J Med, 1997)